The Lancet Neurology reports impact of daridorexant on both nighttime symptoms and daytime functioning in adults with insomnia

/PRNewswire/ -- As reported in the Lancet Neurology, daridorexant is the first insomnia medication to demonstrate an effect of a drug therapy to improve both...

Related Keywords

Canada ,Radnor ,Powys ,United Kingdom ,United States ,Paris ,France General ,France ,Allschwil ,Switzerland General ,Switzerland ,Stanford ,Leicestershire ,American ,Swiss ,Andrewc Weiss ,Ecole Normale Superieure Ulm ,J Clin Pharmacol ,Martine Clozel ,Thomase Scammell ,Cliffordb Saper ,Thomasc Chou ,Emmanuel Mignot ,Christopher Clark ,American Psychiatric Association ,Head Of Investor Relations Corporate Communications ,Stanford Center ,Xxvi University ,Idorsia Pharmaceuticals ,Us Head Of Communications ,Idorsia Ltd ,National Institute Of Health Research ,Us Inc ,Research Society ,Howard Hughes Medical Institute Investigator ,National Academy Of Sciences United States ,Swiss Exchange ,National Center On Sleep Disorders Research Advisory ,Institute Of Medicine ,Idorsia Pharmaceuticals Ltd ,Behavioral Sciences ,National Sleep Foundation ,Behavioral Sciences At Stanford University ,Association Of American Physicians ,Narcolepsy Network ,Lancet Neurology ,Stanford University ,Insomnia Daytime Symptoms ,Impacts Questionnaire ,Chief Scientific Officer ,Enforcement Administration ,Full Prescribing Information ,Medication Guide ,Ecole Normale Superieure ,Craig Reynolds Professor ,Sleep Sciences ,National Institute ,Health Research Awards ,Mcknight Neuroscience ,Young Investigators ,Academic Achievement Award ,American Physicians ,National Academy ,Sleep Research Society ,National Center ,Sleep Disorders Research Advisory ,Scientific Counselors ,Thursday January ,Statistical Manual ,Mental Disorders ,Discov Today Dis ,Statistics Canada ,Drug Metabolism ,Neurosciences Vol ,Vice President ,Investor Relations ,Pharmaceuticals Ltd ,Idorsia Pharmaceuticals Us ,